Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (11-20 of 1,857) with videos related to

Pageof 186
Sort By:
American Heart Journal|May 1, 1979
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic propertiesW Frishman
Physical Review. B, Condensed Matter|June 15, 1993
Induced negative conductance in multiple-well heterostructuresFrishman, Gurvitz
Biochemical and Biophysical Research Communications|February 27, 1996
DSBC protein: a new member of the thioredoxin fold-containing familyD Frishman
American Heart Journal|May 1, 1980
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 13. The beta-adrenoceptor blocking drugs: a perspectiveW Frishman
American Heart Journal|January 1, 1980
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drugW Frishman
Cardiology in Review|October 26, 2023
The Ten Major Advances in Cardiovascular Medicine During the Past 50 Years: A Clinical Investigator's PerspectiveWilliam H Frishman
Cardiology in Review|February 28, 2024
A New Era in Stroke CareWilliam H Frishman
Heart Disease (Hagerstown, Md.)|November 21, 2002
Are antihypertensive agents protective against dementia? A review of clinical and preclinical dataWilliam H Frishman
Cardiology in Review|November 2, 2020
End of an Era: A Tribute to Joanne Cioffi-PryorWilliam H Frishman
Hospital Practice (Hospital Ed.)|May 1, 1982
Antiplatelet therapy in coronary heart diseaseW H Frishman
Pageof 186

Showing results (11-20 of 1,857) with videos related to

Sort By:
Pageof 186
American Heart Journal|May 1, 1979
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic propertiesW Frishman
Physical Review. B, Condensed Matter|June 15, 1993
Induced negative conductance in multiple-well heterostructuresFrishman, Gurvitz
Biochemical and Biophysical Research Communications|February 27, 1996
DSBC protein: a new member of the thioredoxin fold-containing familyD Frishman
American Heart Journal|May 1, 1980
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 13. The beta-adrenoceptor blocking drugs: a perspectiveW Frishman
American Heart Journal|January 1, 1980
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drugW Frishman
Cardiology in Review|October 26, 2023
The Ten Major Advances in Cardiovascular Medicine During the Past 50 Years: A Clinical Investigator's PerspectiveWilliam H Frishman
Cardiology in Review|February 28, 2024
A New Era in Stroke CareWilliam H Frishman
Heart Disease (Hagerstown, Md.)|November 21, 2002
Are antihypertensive agents protective against dementia? A review of clinical and preclinical dataWilliam H Frishman
Cardiology in Review|November 2, 2020
End of an Era: A Tribute to Joanne Cioffi-PryorWilliam H Frishman
Hospital Practice (Hospital Ed.)|May 1, 1982
Antiplatelet therapy in coronary heart diseaseW H Frishman
Pageof 186